ISSN: 2642-4533
Annals of Microbiology and Research is an open access, peer reviewed journal covering comprehensive research in five major groups of microorganisms-viruses, bacteria, fungi, algae and protozoa. The journal invites distinguished research concepts in concern with their form, structure, reproduction, physiology, metabolism, classification and most importantly their economic importance. This helps bringing awareness about the micro living creatures, their role in human biology and other beneficiary applications in bringing up economic importance in health care.
Annals of Microbiology and Research is launched successfully and would establish under the presence of the subject peers to closely scrutinize each of the submitted content received to ensure high impact quality and scientific validity. It invites various types of manuscript forms such as original, reviews, commentaries, cases, rapid communication and other short articles.
Annals of Microbiology and Research is free to access and has no restriction barriers. All the published content is made available freely under Creative Common Attribution License.
President
Biodeterioration Control Associates
Princeton, New Jersey
United States of America
Tel: 609-716-0200
Professor
Department of Biology
University of Texas at San Antonio
United States of America
Tel: 210-458-5663
Professor
Department of Pediatrics
University of Turin
Italy
Tel: +390-11313-5257
Professor
Department of Microbiology and Immunology
Chicago Medical School
United States of America
Tel: 847-578-8837
President
CalRecovery Inc
Concord, California
United States of America
Tel: +1-925-356-3700
Associate Professor
Department of Animal Sciences
The Ohio State University and Ohio State
United States of America
Tel: 1-330-263-3796
Submit your manuscript to this journal through online or email us at editorialoffice@scholars.direct
Original Article
Rise of the Phoenix: Mucormycosis in the Context of COVID-19
Opportunistic infections are especially common in patients who, apart from the current COVID-19 disease, also have other comorbidities such as diabete... Read more
Case Report
Long Term Azithromycin use Reverses Post COVID-19 Lung Inflammation AND Fibrosis
Corona Virus (COVID-19) disease has affected large number of people around the globe. Pandemic still not in control and it is still causing significan... Read more
Research Article
At a time when vaccines are spreading, there are still pockets of resistance, mainly of a social, psychological and behavioral nature, but also of an ... Read more
Research Article
Ten days after first vaccination, 64.6% (n = 42) and 66.2% (n = 43) were S-Ab (total and IgG) positive; however, only 13.8% (n = 9) and 10.8% (n = 7) ... Read more
Research Article
Uropathogenic extended-spectrum beta-lactamases-producing Enterobacteriaceae (ESBL-PE) remains a global cause of urinary tract infections (UTIs) among... Read more
Case Report
The cause of Coronavirus disease 2019 (COVID-19) is the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is sadly well known for th... Read more
Communication
In the context of the exponential growth of the pandemic, everyone has to make some decision: When there is a world shortage of material (screening te... Read more
Review Article
Estimation of Clinical Comorbidities in COVID-19 Patients: A Systematic Review and Meta-analysis
The novel coronavirus or COVID-19 has become a catastrophic global crisis due to its accelerated upsurge in cases. Most hospital admissions and deaths... Read more
Commentary
Since December 2019, over two million people worldwide have been affected by coronavirus disease 2019 (COVID-19). Because of quarantine measures, over... Read more
Commentary
COVID-19: Where we Started and Where we Stand
Coronavirus disease 2019 (COVID-19) is a new infectious disease classified as a pandemic by the World Health Organization on March 11th, 2020. It is c... Read more
